MedPath

Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular Conflict

Not yet recruiting
Conditions
Tic Douloureux
Trigeminal Neuralgia
Facial Pain
Glossopharyngeal Neuralgia
Hemifacial Spasm
Neurovascular Conflict
Registration Number
NCT07135024
Lead Sponsor
Gerrit A Schubert
Brief Summary

The aim of the registry is a multicenter, prospective long-term data collection of patients suspected neurovascular conflict and referred for possible microvascular decompression (Jannetta procedure). The registry relies exclusively on routinely collected clinical data, which are gathered in a standardized and privacy-compliant manner as part of everyday clinical practice. By systematically compiling this information across multiple centers, valuable insights into the effectiveness, potential side effects, and long-term outcomes of this surgical treatment can be gained. The registry will serve as a foundation for future scientific analyses and is intended to help answer relevant research questions regarding the treatment of trigeminal neuralgia based on solid evidence.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
5001
Inclusion Criteria
  • suspected neurovascular conflict
  • signed consent for further use of routine clinical data as accepted by local regulations
Exclusion Criteria
  • refusal of further use of routine clinical data

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Face specific pain relief after surgical treatmentFrom enrolment to last follow-up 5 yrs after surgery

Efficacy of microvascular decompression surgery, defined by the change in facial pain and pain interference as assessed by the patient using the Brief Pain Inventory-Facial (BPI-Facial), with numerical scores ranging from 0 to 10, where higher scores represent worse outcomes.

Pain relief after surgical treatmentFrom enrolment to last follow-up 5 yrs after surgery

Efficacy of microvascular decompression surgery, defined by the change in pain as assessed by the patient using the Visual Analog Scale (VAS) from 0 to 100 mm, with higher scores representing worse outcomes.

Secondary Outcome Measures
NameTimeMethod
Patient satisfaction5yrs after index surgery

Perceived benefit of surgery as determined by Patient global impression of change (PGIC) scores. The PGIC is a 7-point, patient-reported scale that captures an individual's overall perception of change in their condition. It ranges from "very much improved" to "very much worse," enabling patients to rate whether they feel their health has improved, remained the same, or declined.

Effect of surgical treatment on quality of life5 years after index surgery

Efficacy of microvascular decompression surgery as defined by change of Quality of Life Questionaire as measured by EQ-5D-5L. The EQ-5D-5L is a standardized, patient-reported outcome measure that assesses health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels of severity, ranging from "no problems" to "extreme problems.

Surgical complicationsthree months after index surgery

any complications directly attributable to the surgical intervention

Need for additional treatment5 years after index surgery

rate of patients having to undergo additional surgery / intervention / medication after microvascular decompression

Trial Locations

Locations (2)

Dept. of Neurosurgery, RWTH Aachen University Hospital, RWTH Aachen University

🇩🇪

Aachen, NRW, Germany

Dept. of Neurosurgery, Cantonal Hospital Aarau

🇨🇭

Aarau, Aargau, Switzerland

Dept. of Neurosurgery, RWTH Aachen University Hospital, RWTH Aachen University
🇩🇪Aachen, NRW, Germany
Hans Clusmann, Univ.-Prof. Dr. med.
Contact
+49 241 8088481
hclusmann@ukaachen.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.